Ortho Regenerative Technologies Inc.
Ortho RTi is an emerging Orthopaedic and Sports Medicine technology company dedicated to the development of novel therapeutic tissue repair technology to dramatically improve the success rate of sports medicine surgeries for soft tissue injuries. Our proprietary biopolymer has been specifically designed to increase the healing rates of injuries to tendons, meniscus and cartilage. The polymer can be directly placed into the site of injury by a surgeon during a routine operative procedure without significantly extending the time of the surgery and without further intervention.
Ortho Regenerative Technologies Inc. (ORTH)
Sorry, no SEDAR information can be found with the above criteria.
le 5 octobre/October 2017
The common shares of Ortho Regenerative Technologies Inc. have been approved for listing on the CSE.
Listing and disclosure documents will be available at www.thecse.com.